Lewis Campbell is the Managing Director of Target Healthcare, a major UK pharmaceutical manufacturer and distributor headquartered in Scotland. An alumnus of Saïd Business School, University of Oxford, he founded the company in 2012 and has driven its significant expansion through organic growth and strategic acquisitions, including a major deal in 2022.
He has a stated passion for healthcare innovation and enabling global access to medicines. Under his leadership, the company has grown from two employees to over 500, supplying pharmacies, hospitals, and wholesalers across the UK, Europe, and the Middle East.
His acquisition of a division from Clinigen PLC was named "Transformational Deal of the Year" at the 2022 Deal and Dealmaker Awards.